Publications:

Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral Evaluation.

Journal Of Medicinal Chemistry

Curreli, Francesca F; Ahmed, Shahad S; Benedict Victor, Sofia M SM; Iusupov, Ildar R IR; Belov, Dmitry S DS; Markov, Pavel O PO; Kurkin, Alexander V AV; Altieri, Andrea A; Debnath, Asim K AK

Publication Date: 2020-02-27

Variant appearance in text: CYP2B6: N42S

PubMed Link: 32031803

Variant Present in the following documents:

• Main text

View BVdb publication page